Article

Psychopharmacology of Personality Disorders

Kenneth R. Silk and Louis Feurino

in The Oxford Handbook of Personality Disorders

Published in print September 2012 | ISBN: 9780199735013
Published online November 2012 | | DOI: http://dx.doi.org/10.1093/oxfordhb/9780199735013.013.0033

Series: Oxford Library of Psychology

 Psychopharmacology of Personality Disorders

More Like This

Show all results sharing these subjects:

  • Psychology
  • Clinical Psychology

GO

Show Summary Details

Preview

The purpose of this chapter is to review the literature concerning the psychopharmacology of personality disorders. We first review the double-blind placebo-controlled pharmacologic studies of all the personality disorders, except for borderline personality disorder (BPD). Attention is then focused on BPD. While there have been many open-labeled studies, there are fewer than 30 randomized-controlled trials even for this personality disorder. The section on borderline personality disorder will conclude with guidance as to how to think about the management of the actual pharmacologic treatment of this disorder, including matters such as dosage, lethality, augmentation, and avoiding polypharmacy. We conclude with a discussion of the obstacles hampering the development of a more substantial database that could provide guidance and direction.

Keywords: psychopharmacology; pharmacotherapy; polypharmacy; treatment; medication; personality disorders; borderline

Article.  10260 words. 

Subjects: Psychology ; Clinical Psychology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.